Literature DB >> 21602111

Risk factors and outcomes of cytomegalovirus viremia in cancer patients: a study from a medical center in northern Taiwan.

Yung-Chih Wang1, Ning-Chi Wang, Jung-Chung Lin, Cherng-Lih Perng, Kuo-Ming Yeh, Ya-Sung Yang, Chun-Hsiang Chiu, Feng-Yee Chang.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) is a pathogen and can cause life-threatening infection in the patients with malignancies. This study was conducted to investigate the risk factors and outcomes of CMV viremia in patients with malignancies.
METHODS: Data were collected with retrospective analysis from adults suffering from CMV viremia with underlying malignancies. A total of 107 patients were enrolled in a tertiary medical center in northern Taiwan from March 2008 to December 2009.
RESULTS: Among the 107 patients who suffered with CMV viremia with an overall mortality rate of 56.1% (60/107), 75 patients (70.1%) had solid organ malignancies and 32 (29.9%) had hematological malignancies. Mechanical ventilation (p=0.048), leukocytosis (p=0.004), and lack of appropriate early treatment (p=0.011) were independent predisposing factors associated with higher mortality rate.
CONCLUSIONS: CMV viremia predicts high mortality rate in cancer patients, especially in those with mechanical ventilation, leukocytosis, and lack of appropriate early treatment. Appropriate early antiviral therapy is recommended to improve outcomes.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602111     DOI: 10.1016/j.jmii.2011.04.004

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  5 in total

Review 1.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

2.  Cytomegalovirus infection in malignant pleural mesothelioma.

Authors:  DeVon Hunter-Schlichting; Karl T Kelsey; Ryan Demmer; Manish Patel; Raphael Bueno; Brock Christensen; Naomi Fujioka; Deepa Kolarseri; Heather H Nelson
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

3.  Cytomegalovirus reactivation and its clinical impact in patients with solid tumors.

Authors:  Konstantin Schlick; Michael Grundbichler; Jutta Auberger; Jan Marco Kern; Markus Hell; Florian Hohla; Georg Hopfinger; Richard Greil
Journal:  Infect Agent Cancer       Date:  2015-12-03       Impact factor: 2.965

4.  Cytomegalovirus Colitis Masquerading as Apple-Core Lesion after Systemic Chemotherapy in a Patient with Relapsed Acute Myeloid Leukemia.

Authors:  Jong An; Jason Brownell; Darrell Barker; Theresa Stockinger; Robert Brady; Katherine Cebe; Russell Baur
Journal:  Case Rep Oncol Med       Date:  2018-03-20

Review 5.  Interplay Between Calcium and AMPK Signaling in Human Cytomegalovirus Infection.

Authors:  Diana M Dunn; Joshua Munger
Journal:  Front Cell Infect Microbiol       Date:  2020-07-29       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.